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2Abstract
Mutations of the survival motor neuron gene SMN1 cause the inherited disease spinal
muscular atrophy. The ubiquitous SMN protein facilitates the biogenesis of spliceosomal
small nuclear ribonucleoproteins, snRNPs. The protein is detected in the cytoplasm,
nucleoplasm and enriched with snRNPs in nuclear Cajal bodies. It is structurally divided at
least into an amino-terminal region rich in basic amino acid residues, a central Tudor domain,
a self-association tyrosine/glycine-box and an exon7-encoded carboxy-terminus. To examine
the domains required for the intranuclear localization of SMN, we have used fluorescently
tagged-protein mutants transiently overexpressed in mammalian cells. The basic amino acid
residues direct nucleolar localization of SMN mutants. The Tudor domain promotes
localization of proteins in the nucleus and it cooperates with the basic amino acid residues and
the tyrosine/glycine-box for protein localization in Cajal bodies. Moreover, the most frequent
disease-linked mutant SMNDex7 reduces accumulation of snRNPs in Cajal bodies, suggesting
that the C-terminus of SMN participates in targeting to Cajal bodies. A reduced number of
Cajal bodies in patient fibroblasts associates with the absence of snRNPs in Cajal bodies,
revealing that intranuclear snRNA organization is modified in disease. These results indicate
that both direct and indirect mechanisms regulate localization of SMN in Cajal bodies.
3Introduction
Proximal spinal muscular atrophy (SMA) is a group of autosomal recessive
neuromuscular disorders with childhood onset characterized by motor neuron degeneration
and progressive paralysis. The disease is caused by mutations of the gene encoding the
survival motor neuron (SMN) protein, SMN1 (Lefebvre et al., 1995). SMN1 and its nearly
identical copy, SMN2, are within duplications on chromosome 5q13. Compared to SMN1,
SMN2 is unique in that a single nucleotide change generates alternative splicing of SMN2
exon 7 (ex7), resulting in replacement of the C-terminal 16 amino acids (aa) by a 4-aa
sequence (SMNDex7). Indeed, it has been demonstrated that this unique nucleotide is
included in a splice enhancer (Hofmann et al., 2000; Cartegni et al., 2002) and/or a splice
inhibitor site (Kashima and Manley, 2003). The identical full-length SMN1 and SMN2
transcripts produce the ubiquitous 38 kDa SMN protein (Liu and Dreyfuss, 1996; Coovert et
al., 1997; Lefebvre et al., 1997). A close correlation exists between the reduced levels of the
SMN protein and the severity of SMA disease (Coovert et al., 1997; Lefebvre et al., 1997).
The level of SMN fluctuates considerably in different cell types and during development
(Burlet et al., 1998; La Bella et al., 1998). This modulation appears to be a key to its function,
since the integrity of nuclear bodies (NBs) could be disrupted after SMN depletion in SMA
patients and mouse models (Schrank et al., 1997; Frugier et al., 2000; Hsieh-Li et al., 2000;
DiDonato et al., 2001; Monani et al., 2003). Why SMN and SMNDex7 isoforms exist remains
unknown. It is recognized that they have different functional properties, such that SMNDex7,
which preponderates in SMA patients, does not fully compensate for the absence of SMN1
(Lefebvre et al., 1995). The mechanism by which SMN depletion induces the neuromuscular
defect is still elusive.
The SMN protein localizes mostly in the cytoplasm and accumulates in nuclear bodies
frequently overlapping with Cajal bodies (CBs), named gems (gemini of CBs; Liu and
Dreyfuss, 1996). SMN is a component of a large multiprotein complex comprising gemin2 to
7, which participates in the assembly of proteins and RNAs (reviewed in Meister et al., 2002a;
Gubitz et al., 2004). Particularly, it has been shown that SMN facilitates various steps of the
biogenesis of the spliceosomal U snRNPs (Uridine-rich small nuclear ribonucleoproteins) that
are part of the spliceosome essential for the removal of introns during pre-mRNA splicing.
The biogenesis of snRNPs (U1, U2, U4 and U5) constitutes a complex pathway occurring in
both the cytoplasm and nucleus (Will and Luhrmann, 2001). The SMN complex facilitates
cytoplasmic assembly of spliceosomal Sm core proteins onto U snRNAs and recruitment of
the snRNA cap hypermethylase (TGS1; Mouaikel et al., 2003), leading to the formation of
4nuclear import-competent snRNPs. The SMN complex remains associated with the snRNPs
along the entire cytoplasmic pathway (Massenet et al., 2002). In the nucleus, it appears that
the CB-containing the SMN complex are the first sites of accumulation of newly imported
snRNPs (Carvalho et al., 1999, Sleeman et al., 2001) and are involved in early nuclear stages
of snRNA maturation (Jàdy et al., 2003).
SMN is encoded by eight exons generating a multidomain polypeptide of 294 aa (see
Fig.2A). It contains the central Tudor domain flanked by a N-terminal lysine (K)-rich
sequence and in the C-terminal region, by a proline (P)-rich, a tyrosine/glycine (YG)-box and
the ex7 encoded domains. The Tudor domain, named because of its structural homology to
repeats of the Drosophila tudor protein, is conserved among different RNA-binding proteins
(Pontig, 1997; Selenko et al., 2001) and mediates SMN interaction with arginine-glycine (RG)
motifs in several proteins (reviewed in Meister et al., 2002a; Gubitz et al., 2004), including
the CB marker coilin and the Sm core proteins and their symmetrically dimethylated arginine
(sDMA) isoforms (Friesen et al., 2001; Meister and Fischer., 2002b; Hebert et al., 2002;
Boisvert et al., 2002). The K-rich sequence is embedded in the interspecies conserved RNA-
binding domain (Lorson and Androphy, 1998a; Bertrandy et al., 1999). The P-rich domain
associates with the actin-binding protein profilin (Giesemann et al., 1999). The YG-box
domain is implicated in self-association in vitro (Lorson et al., 1998b) and a putative
cytoplasmic retention signal is encoded by ex7  (Zhang et al., 2003).
Unravelling mechanisms by which a protein is localized to various subnuclear
compartments is primordial to understand nuclear organization and human diseases (Phair and
Misteli, 2000; Carmo-Fonseca et al., 2002; Bubulya and Spector, 2004; Zaidi et al., 2004).
Thus far, no clear overview of the role of the SMN domains, particularly of the Tudor
domain, in subnuclear localization exists (Mohaghegh et al., 1999; Le et al., 2000). The
overexpressed SMA mutant SMN472D5 lacking the C-terminal half of SMN is localized
throughout the nucleus (Lefebvre et al., 2002). Why SMN472D5 presents such a distribution
has awaited further investigations. Here, we have systematically analysed the functional SMN
domains and showed that they govern nucleocytoplasmic partition and intranuclear
localization in the nucleoplasm, nucleoli and gems/CBs. The central Tudor domain cooperates
with the YG-box and the K-rich sequence for the accumulation of SMN in CBs. The U
snRNPs fail to concentrate in CBs of cells transiently transfected with the SMA mutant
SMNDex7, suggesting a role of the ex7 domain for the localization of U snRNPs in CBs.
Furthermore, in fibroblasts of SMA patients there is no accumulation of snRNPs in NBs,
indicating that SMN depletion affects the spatio-temporal distribution of snRNPs.
5Materials and Methods
Engineered fluorescently tagged proteins
Full-length and SMN mutants were prepared by PCR-amplification from full-length human
cDNA (Lefebvre et al., 1995), digested and subcloned into the appropriate restriction sites of
the pEGFP vectors (Clontech). Subcloning the RT-PCR fragment from total RNA preparation
of an SMA patient produced SMNDex7. Mutations were introduced in the GFP recombinants
using the QuickChange mutagenesis kit (Stratagene). Oligonucleotides used for mutagenesis
are available upon request. DNA sequencing and FP-immunoblotting confirmed the
constructs.
Cell cultures and transfections
COS7, HeLa and human fibroblast cultures were maintained in DMEM supplemented with
10% FBS, penicillin (100 U/ml) and streptomycin (100 mg/ml). Cells were plated in a 8-
chamber culture Slide (Becton Dickson Lab.) and transfected with purified plasmid using
FuGENE 6 (Roche Diagnostics) as described previously (Lefebvre et al., 2002).
Immunofluorescence and microscopy
At 16-48h post-transfection, COS and human cells were prepared for fluorescence
microscopy (Lefebvre et al., 1997). The following antibodies were used: anti-TMG (mouse
mAb at 1:4000, Calbiochem), anti-U2 snRNP-specific protein U2B” (4G3 mouse mAb at
1:200, ICN Pharmaceuticals), anti-coilin (mouse mAb at 1:125, Abcam or a kind gift from M.
Carmo-Fonseca), anti-SMN (mouse mAb at 1:500, Trans Lab or 4B3 at 1:500, Burlet et al.,
1998), purified rabbit anti-SMN peptide (1:500), secondary anti-rabbit and anti-mouse Cy3
(1:500, Jackson Laboratories) and anti-mouse Alexa 488 (1:500, Molecular Probes). Samples
were incubated with 4,6-diamidino-2-phenylindole (DAPI, 0.1 mg/ml), mounted in either AF1
(Cityfluor) or Mowiol (Hoechst) and observed by nonconfocal (Leica DMR, objective
63x/1,32) or confocal (LEICA TCS SP2 AOBS, objective 63x/1,32) microscopy.
Nonconfocal images acquired with a cooled CCD camera (Micromax, Princetown
Instruments, Inc.) using MetaView Imaging System were processed by ImageJ
(rsb.info.nih.gov/ij) and prepared using Adobe photoshop.
Analysis of the fluorescence signals
Fluorescence images were acquired as a series (stack) of optical sections of 1 mm along the
6optical axis (z) of the entire cell using a on a confocal microscope (LEICA TCS SP2 AOBS).
The sensitivity of the photomultiplier tube was adjusted so that the fluorescence signal of the
FP-fusion proteins was below the saturation level. The monographies (512x512 pixels) of
each optical section were captured as 8-bit grayscale images. A segmentation algorithm was
used to define the ‘objects’ by applying a threshold to each of the z-sections (ImageJ). The
same segmentation algorithm was applied to automatically define the nuclear region by DAPI
staining of each z-section. The proportion of fluorescence within the nucleus was calculated
using ImageJ and was expressed as the percentage of the total fluorescence contained in the
entire stack of z-sections. Ten cells were randomly selected and examined for each construct.
The results presented values obtained from independent experiments and the significance was
determined using the non-parametric Mann-Whitney test.
Flow cytometry
Cell sorting was performed with an EPICS Elite - ESP flow cytometer (Beckman-Coulter)
equipped with a 15 mw argon-ion laser emitting at 488 nm and collecting through a 520 + 15
nm bandpass filter for eGFP measurements. Sort windows were set to include cells with
correct scatter profile and positive eGFP fluorescence.
Co-immunoprecipitations
The anti-GFP (Clonetech), anti-TMG (Calbiochem) and normal antibodies (DAKO) were
incubated overnight at 4°C with total protein lysates from transfected cells with RIPA buffer
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP40, 0.1% SDS) in presence of RNAsin (1
U/ml, Promega) and protease inhibitors, and bound to Dynabeads M-280 sheep anti-rabbit or
anti-mouse IgG (Dynal) for 2 hr at 4°C (Lefebvre et al., 2002). After four washes in RIPA,
the proteins were eluted in SDS loading sample buffer and resolved by SDS-PAGE.
Immunoblot analyses
The proteins resolved by SDS-PAGE were transferred to a PVDF membrane and
incubated with antibodies directed against GFP (mouse mAb at 1:1000, Roche Diagnostics),
SMN (mouse mAb at 1:1000, Transduction Laboratories), gemin2 (mouse mAb at 1:1000,
Abcam), Sm proteins (Y12 mouse mAb at 1:500, Abcam) and a-tubulin (mouse mAb at
1:10000, Sigma). The membranes were incubated with horseradish peroxidase-conjugated
secondary antibody and detected by chemiluminescence (Amersham).
7Results
The fluorescently tagged SMN protein behaves like the endogenous SMN
The localization of transiently expressed fluorescently tagged (FP)-SMN in COS cells
and immortalized Type I (severe) SMA fibroblasts was compared to the localization of the
endogenous SMN (Fig. 1). Immunofluorescence microscopy showed that SMN localized in
the cytoplasm and concentrated in NBs in COS cells as reported in HeLa cells (Fig. 1A, Liu
and Dreyfuss, 1996). In immortalized Type I SMA fibroblasts containing residual levels of
SMN (Lefebvre et al., 2002), SMN was detected in the cytoplasm, nucleoplasm and
occasionally, in NBs (Fig. 1D). Each cell line was transfected with FP-SMN and the
distribution of transfected and endogenous SMN was similar (Fig. 1B, E). To determine if
SMN localizes in gems and/or CBs in COS cells, we examined the localization of the CB
marker coilin and of the gems markers SMN and gemin2. Analyses of the localization of
SMN and coilin foci showed that SMN and coilin colocalized in CBs (Fig. 1G) in over 71%
of cells (n=704) and there were no nuclear foci in the remainder of cells. The SMN and
gemin2 foci were completely colocalized (Fig. 1H) in 64% of cells (n=602). Further
immunofluorescence studies showed that SMN and 2,2,7-trimethylguanosine (TMG)-capped
snRNAs of snRNP foci were colocalized (Fig. 1I) in 35% of cells (n=105). In most cell types
(Carvalho et al., 1999; Young et al., 2001a) and in COS cells, gems and CBs constituted the
same nuclear substructure.
The Tudor domain is not sufficient for SMN localization in CBs
The RG-motif of coilin serves to recruit the SMN to CBs (Hebert et al., 2002), but the
SMN Tudor domain interacts with the RG-motif of other proteins (reviewed in Terns and
Terns, 2001; Meister et al., 2002a; Gubitz et al., 2004), and it seemed likely that localization
in CBs might involve other regions of SMN. To test this hypothesis, we generated (Fig. 2A)
and transiently overexpressed a series of fluorescently tagged SMN deletion mutants in COS
cells. We chose the primate COS cells that do not have the SMN2 gene and consequently, do
not express the SMNDex7 transcript. The integrity of fusion proteins was first verified by
immunoblotting analyses (Fig. 2B). Each construct expressed a protein at the expected
position. Given the transfection efficiency, the levels of fusion proteins were comparable,
except for ex2B, as judged by both anti-tubulin and anti-SMN incubations.
Protein localization in transfected COS cells was analysed by fluorescence microscopy
(Fig. 2C). SMN protein was first divided into three fragments containing the N-terminal
region FP-SMNN86 (aa 1-86, N86), the central Tudor domain FP-SMNTudor (aa 87-146,
8Tudor) or the C-terminal region FP-SMNDN189 (aa 190-294, DN189). All these failed to
accumulate in nuclear foci, demonstrating that none of these regions alone contains sufficient
information for targeting to NBs. Fragments N86 and Tudor accumulated in respectively
nucleoli and irregularly shaped nuclear substructures resembling speckles, and DN189 was
localized in the cytoplasm. These results indicated that the sequences necessary for
localization in NBs encompassed more than one region covered by the deletions.
It was first possible to conclude that a combination of N86 and the Tudor domain
contributed to the localization of the SMA mutant SMN472D5 (aa 1-146, 472D5) in NBs.
This mutant also localizes in the nucleoplasm and nucleoli (Fig. 2C; Lefebvre et al., 2002).
Previous studies have implicated protein self-association in the formation of NBs (Hebert et
al., 2000). A self-association domain has been mapped to the region encoded by SMN exon2B
(aa 52-91; Young et al., 2000). To explore the role of this domain in localization, the
construct FP-SMNex2B (aa 52-86) was generated and overexpressed: no fluorescence signal
was observed in NBs, the protein being nuclear and concentrated in nucleoli, as judged by
DAPI staining (Supplemental Fig. S1). We performed further mutagenesis experiments to
identify which residues of the N-terminal region were responsible for the accumulation of
SMN472D5 in NBs. The SMNex2B contains a K-rich sequence reminiscent of a cryptic
nucleolar localization signal (NoLS) in coilin (Hebert et al., 2000) and similar to a consensus
sequence for K-dependent NoLS (Horke et al., 2004; Fig. 2D). In view of the functional links
between nucleoli and CBs (reviewed in Gall, 2003), we substituted the basic residues by
asparagine (N) in FP-SMN472D5M2 (71NNNPANNNN79, 472D5M2) and in FP-SMNN86M2
(N86M2). The two mutants were localized exclusively in the nucleoplasm (Fig. 2D),
indicating a contribution of the Tudor and K-rich domains in targeting SMN to CBs.
To further address the role of self-association in the localization of SMN, we tested
deletions of the C-terminal ex7 and YG-box regions, which are involved in self-association of
SMN (Lorson et al., 1998a). FP-SMNDex7 (consisting of aa 1-278 plus the first 4 aa from
ex8, Dex7) localized in the cytoplasm, nucleoplasm and nuclear foci (Mohaghegh et al., 1999;
Le et al., 2000). Additional deletion of the YG-box in FP-SMNDC40 (aa 1-254, DC40)
showed a diffuse cytoplasm with a few aggregates (Fig. 2C). The simplest interpretation for
these aggregates would be that they are due to proline stretches at the C-terminus of the
protein. In the nucleus, DC40 was detected exclusively in the nucleoplasm, as were
SMNDex6/7 (aa 1-278; Vyas et al., 2002) and FP-SMNN194 (aa 1-194, N194, Fig. 2C).
These results suggest that proline stretches move N194 away from NBs when compared with
9472D5 and that the self-association YG-box enhances the localization of SMN to NBs. To test
this possibility, we generated FP-SMNDN86 (aa 87-294, DN86) that corresponds to the
addition of the Tudor domain to the C-terminal region DN189. DN86 localized in the
cytoplasm and in contrast with DN189, accumulated in NBs, indicating that the Tudor and
YG-box domains cooperate to localize in NBs (Fig. 2C). In addition, DN86 showed large
cytoplasmic aggregates (blobs), which were not observed by overexpression of full-length FP-
SMN (Fig. 1B) under our experimental conditions. In other studies the FP-SMN was shown to
form cytoplasmic aggregates upon high expression levels (Shpargel et al., 2003; Sleeman et
al., 2003). To exclude the possibility that localization in NBs was mediated by endogenous
SMN, immortalized type I SMA fibroblasts with almost no NBs (6% of cells) were
transfected with SMN constructs (Figs 1E, S2: Dex7, 472D5 and Tudor shown only).
Localization in NBs of SMN mutants appears independent of the levels of endogenous SMN,
indicating that transfected proteins present intrinsic properties. Similar localization patterns
were also obtained in transfected HeLa cells (Fig. S3).
The NBs formed by the SMN mutants in transfected COS cells were further examined
by immunofluorescence labelling of CB marker coilin. Coilin-positive CBs were nuclear
substructures present in cells expressing the SMN mutants (Fig. 3, Table 1). The nuclear foci
in FP-SMN transfected cells showed complete colocalization of FP-SMN and coilin. The
SMN mutant Dex7, 472D5 and DN86 also showed complete colocalization with coilin in
nuclear foci and they can be considered as CBs. However, the number of coilin foci obtained
with these mutants was greater than in FP-SMN transfected cells, which was comparable to
the number of foci in untransfected cells (Fig. 1G). In contrast, the FP signal failed to
accumulate in CBs of cells transfected with N86, Tudor, ex2B, DC40 or DN189 (Fig. 3). Our
results indicate that overexpression of SMN deletion mutants does not interfere with the
ability of CBs to accumulate coilin.
Multiple interacting motifs regulate the nucleocytoplasmic distribution of SMN
To further characterize the nucleocytoplasmic distribution of FP-fusion proteins, we
examined the ratio of fluorescence intensity in the nucleus versus the whole cell by confocal
microscopy (Fig. 4A). The heterogeneity in fluorescence partitioning of some constructs was
possibly due to cytoplasmic signals outside the threshold range. The analyses revealed that
DN86 and FP-SMN had similar nuclear proportion of fluorescence (Mann-Whitney test, not
significant at P£5%), indicating that removal of the N-terminal region has no effect on
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nucleocytoplasmic partitioning of SMN. The fraction of Dex7 associated with the nucleus was
significantly increased compared to FP-SMN (P£5%). The nuclear fraction of DC40 was also
increased compared to Dex7 (P£5%). These results indicate that efficient oligomerization
mediated by the YG-box and ex7 domain contributes to the nucleocytoplasmic distribution of
SMN. Additional removal of aa 147 to 194 encoded by exon 4 caused the increase of 472D5
in the nucleus compared to DC40 and N194 (P£5%). We then tested whether accumulation in
CBs might influence the value of the nuclear fraction. 472D5 and 472D5M2 were similarly
associated with the nucleus, indicating that CB accumulation was dispensable for nuclear
localization. In addition, the nuclear fraction of both the Tudor and ex2B regions increased
compared to the other SMN constructs (P£5%). To further assess their importance in nuclear
localization of SMN, the ex2B and Tudor regions were independently fused to the
cytoplasmic protein 14.3.3g conjugated to eGFP (Strochlic et al., 2004, Fig. 4B-D): only the
Tudor domain contained information to localize the protein in the nucleus. This agrees with
the observation that partial deletion of the ex2B region has no major effect on the
nucleocytoplasmic distribution of SMN (Le et al., 2000). From these studies we concluded
that SMN has no classical NLS and that nuclear accumulation is regulated positively by the
Tudor domain and negatively by the C-terminal portion of SMN.
SnRNPs presence is not critical for the localization of SMN mutants in CBs
It has been shown that overexpression of SMNDN27 lacking the first 27 N-terminal aa
results in the redistribution of the snRNPs to enlarged cytoplasmic and nuclear structures
(Pellizzoni et al., 1998). To extend these observations, we determined whether our SMN
mutants localized in CBs due to the presence of snRNPs (Table 1, Fig. 5). The distribution of
the TMG-capped snRNA of snRNPs was examined. The speckled nucleoplasmic distribution
of TMG in transfected cells appeared similar to that of untransfected cells (Fig. 1I), indicating
no striking effect of the transfected SMN mutants tested over the nucleoplasmic pool of
snRNPs (Fig. 5A). TMG foci were detected in cells transfected with N86 and FP-SMN, as
also in the untransfected cells (Fig. 1I), indicating that overexpression of fluorescently tagged-
proteins per se does not affect the composition of CBs. In contrast, a great reduction in the
number of transfected cells with TMG foci was observed upon the overexpression of Dex7,
DN86 and 472D5 (Pc2£1%). In those cells, the remainder of TMG foci coincided with the FP
foci (Fig. 5A). Overexpression of the Tudor domain, which partially overlapped the
nucleoplasmic snRNPs, also depleted snRNPs from CBs. Immunofluorescence experiments
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using 4G3 monoclonal antibody against the U2 snRNP-specific B” protein confirmed that the
number of snRNPs foci was reduced upon expression of these SMN mutants (Fig. 5B). In
addition, mutant Dex7 led to the accumulation of TMG in CB in 30% of transfected HeLa
cells (n=942, Pc2£1%) compared to 55% and 60% with FP-SMN transfected (n=579) and
untransfected (n=699) cells, respectively. These data indicate that Dex7 leads to reduction of
snRNPs in CBs independently of cell type.
To assess the importance of the association of SMN with the snRNP Sm proteins on
the localization in CBs, we tested the overexpression of FP-SMNE134K (E134K), a mutant
harbouring a glutamic acid to lysine substitution at position 134 in Tudor domain. This
mutation, which has been identified in a Type I SMA patient (Clermont et al., 1997), disrupts
the in vitro binding of SMN to the Sm proteins, fibrillarin and GAR1 (Bülher et al., 1999;
Whitehead et al., 2002). The E134K mutant was localized in the cytoplasm and concentrated
in an increased number of nuclear foci (Fig. 5C; Mohaghegh et al., 1999). Some of the E134K
foci colocalized with coilin in CBs in 52% of transfected cells and they were gems and CBs in
the remainder of cells (Table 1). There were as many TMG foci in E134K-transfected cells as
in untransfected cells, indicating that the E134K mutant did not affect the localization of
snRNP in CBs probably because of its reduced ability to interact with Sm proteins (Buhler et
al., 1999). Taken together with the observations that the other mutants tested depleted the
snRNPs from CBs, these results indicate that SMA mutant E134K does not compete for SMN
binding sites of snRNPs.
To further assess the role of SMN in the distribution of snRNP in CBs, we investigated
the localization of the endogenous SMN in transfected COS cells (Table 1, Fig. 5D).
Immunofluorescence analyses of the endogenous SMN was possible with N86, DN86, Tudor
and 472D5 using an anti-SMN monoclonal antibody against either the N-terminus of SMN or
a bacterially-expressed human SMNDN86 (Burlet et al., 1998). Endogenous SMN
accumulated in nuclear foci of cells transfected with N86, DN86 or Tudor, but no SMN foci
were detected in 472D5-transfected cells (Fig. 5C; Table 1). These results indicate that the
reduction of snRNPs in CBs is not associated with the absence of SMN in CBs.
Endogenous SMN protein associates with SMN mutants in transfected cells
Our results indicated that deletion of the C-terminus of SMN in SMNDex7
significantly affects the localization of snRNPs in CBs. To investigate the consequences of
ex7 deletion in transfected cells, the FP-SMN and FP-SMNDex7 cell populations were
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isolated and the levels of endogenous proteins examined. Immunoblot analyses of protein
extracts from cells transfected with either construct revealed similar molar ratios of SMN,
gemin2, SmB/B’ and fusion proteins as compared to tubulin, indicating that there is no
massive protein degradation upon transfection (Fig. 6A). Immunoprecipitation experiments
performed using anti-GFP and anti-TMG antibodies showed that both FP-SMN and FP-
SMNDex7 are associated with endogenous SMN and gemin2 (Fig. 6B), and with snRNPs
(Fig. 6C-D). Compared to FP-SMN, FP-SMNDex7 displayed a different stoichiometry of the
immunoprecipitated endogenous SMN and gemin2, suggesting that FP-SMN and FP-
SMNDex7 might not form the same complex. Association of FP-SMNDex7 with endogenous
SMN suggests that the depletion of snRNPs from CBs might be due to competitive binding of
FP-SMNDex7 with SMN complexes. Moreover, immunoprecipation experiments revealed
that the SMN truncation mutants N86, 472D5 and DN86 associated with the endogenous
SMN, indicating that they may affect the composition of the SMN complex (Fig. 6E-G). The
Tudor domain did not immunoprecipitate the endogenous SMN, suggesting that deletion of
the N- and C-terminal portions affects incorporation of the fusion protein into SMN complex
(Fig. 6H).
SMA disease affects the distribution of snRNPs in CBs
To determine whether the levels of SMN influence the distribution of snRNPs in CBs,
the intranuclear localization of SMN and TMG-capped snRNA of snRNPs was compared in
immortalized fibroblasts derived from a control and a SMA Type I individual (Fig.7A).
Double-labelling experiments showed complete colocalization of SMN and TMG foci in 40%
of control fibroblasts, SMN foci did not accumulate snRNPs in 10% of cells and the
remainder 50% of cells were devoid of nuclear foci (n= 953). In immortalized SMA Type I
fibroblasts, SMN foci were observed in 6% of cells and these foci did not accumulate TMG
(n=870). These results suggest that SMA patients mislocalize snRNPs. To determine whether
the intranuclear localization of SMN and snRNPs was correlated with phenotypic severity, we
examined the colocalization of SMN and TMG in NBs of sub-confluent primary skin
fibroblasts derived from children affected with Type I (severe), Type II (intermediate) and
Type III (moderate) SMA and a control infant (Fig. 7B-C). Immunofluorescence analyses
showed that in 72% of fibroblasts (n=2037) from a control infant, SMN concentrated in
nuclear foci. The SMN and coilin foci showed complete colocalization in CBs in 20% of
control fibroblasts (n=600). The remaining 52% of cells were devoid of coilin foci, indicating
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that the SMN foci were gems. The SMN and TMG foci showed complete colocalization in
10% of cells (n=1437). The remaining 62% of cells were devoid of TMG foci, indicating that
some of the SMN/coilin foci must be devoid of TMG. The SMA-derived fibroblasts from
Type I (n=913), II (n=1070) and III (n=1069) showed SMN foci in 6, 15 and 20% of cells,
respectively. The SMA patients had a fewer SMN foci and the disease severity correlated with
the number of cells with foci (Coovert et al., 1997). The SMN and coilin foci showed
complete colocalization in SMA-derived fibroblasts from Type I (n=300), II (n=300) and III
(n=200), indicating that the number of gems/CBs is correlated with disease severity. In all
three types of SMA cells SMN foci did not accumulate TMG, indicating that defective snRNP
distribution in CBs associates with the SMA disease.
Immortalized Type I SMA fibroblasts were transiently transfected with the expression
vector encoding the FP-SMN and analysed using antibodies to coilin and TMG of snRNA. In
both transfected (n=203) and non-transfected cells (n=200), coilin localized to nuclear foci in
82% of cells, suggesting that overexpression of FP-SMN does not enhance the formation of
CBs (Sleeman et al., 2001). Cells expressing FP-SMN showed coilin and FP-SMN both
concentrated in CBs (Fig. S2). The FP-SMN-positive NBs accumulated snRNPs in 26% of
transfected cells (n=201). Consequently, transient expression of FP-SMN in SMA cells
expressing reduced levels of endogenous SMN is sufficient to trigger accumulation of
snRNPs in NBs.
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Discussion
In this study we have analysed the accumulation of the SMA gene product SMN in the
nuclear substructures gems and CBs using a series of fluorescent protein-tagged SMN
mutants. Domains governing the nuclear and intranuclear localization of SMN have been
identified. Furthermore, newly assembled spliceosomal snRNPs re-entering the nucleus
associate with SMN (Narayanan et al., 2004) and transiently move into CBs (Sleeman et al.,
2001). The role of CBs in snRNP maturation steps (Jàdy et al., 2003; Nesic et al., 2004) and
in regeneration of snRNPs after splicing has been described (Pellizzoni et al., 1998; Stanek
and Neugebauer, 2004; Schaffert et al., 2004). To better understand the nuclear roles of SMN,
the localization of snRNPs in CBs of cells expressing SMN constructs was investigated. Cells
transfected with SMA mutants show severe reduction of snRNPs in CBs whereas snRNPs
accumulate in CBs of FP-SMN transfected cells. Moreover, in all three types of SMA-derived
fibroblasts the capacity to accumulate snRNPs in CBs is abrogated.
Tudor and self-oligomerization YG-box domains regulate the nucleocytoplasmic
distribution of SMN
The SMN Tudor domain is the prototype of a conserved structural motif found in
nucleic acid-binding proteins (Selenko et al., 2001; Maurer-Stroh et al., 2003). This domain
mediates interactions with a protein motif formed of RG-rich repeats. Moreover, sDMA
residues in the RG-rich C-terminus of snRNP core Sm proteins increases its association to
SMN (reviewed in Meister et al., 2002a; Gubitz et al., 2004). Recent studies have
demonstrated that sDMA-containing proteins are localized in the nucleus (Boisvert et al.,
2002) and several of these interact with the Tudor domain of SMN (Côté and Richard, 2005).
Although the Tudor domain does not contain a classical NLS, we now report that it localizes a
cytoplasmic protein to the nucleus and enhances the nuclear pool of SMA mutant 472D5
compared to N86 that lacks the Tudor domain. Following the current model, Tudor domain-
containing SMN proteins enter the nucleus bound to snRNP Sm proteins and to factors of the
snRNP nucleocytoplasmic trafficking machineries (Buhler et al., 1999; Massenet et al., 2002;
Narayanan et al., 2004). Other examples of proteins co-imported into the nucleus exist, such
as the arginine/serine (RS)-rich splicing factors (Cacéres et al., 1997), the U2 snRNP-specific
U2B’’ protein (Kambach and Mattaj, 1994) and the splicing factor SF3a (Nesic et al., 2004).
The role of the Tudor domain in nuclear localization is consistent with the abrogation
of in vitro import of SMN after immunodepletion of snRNPs or deletion of the Sm-binding
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Tudor domain, Dex3 (Narayanan et al., 2004). Our finding that deletion of the self-
oligomerization YG-box (DC40) enhances nuclear localization as compared to Dex7 is
somewhat unexpected, since mutations within the YG-box interfere with SMN-binding to Sm
proteins (Pellizzoni et al., 1999; Wang and Dreyfuss, 2001) and deletion of this domain
(Dex6) abrogates SMN import in vitro (Narayanan et al., 2004). However, nuclear localization
of DC40 is consistent with the ability of the Tudor domain to interact in vitro with the general
import factor importin-b in the context of Dex6 (Narayanan et al., 2004). Taken together,
these results support the view that Tudor and self-oligomerization YG-box modulate
nucleocytoplasmic partitioning of SMN.
Moreover, the finding that removal of the Tudor domain in DN189 does not diminish
the nuclear fraction as compared with DN86, suggests that other mechanisms play a role in the
nuclear localization of SMN proteins. Indeed, the association of the C-terminus of SMN with
the zinc finger protein ZPR1 might regulate nuclear partitioning of SMN (Gangwani et al.,
2005). If SMN can enter the nucleus only with the snRNPs, our results suggest the existence
of different pathways for snRNP import, as previously postulated (Fischer et al., 1991).
Cooperation between domains regulates the localization of SMN in CBs
Our finding that the Tudor domain is essential but not sufficient for the localization of
SMN proteins in CBs is somewhat unexpected, since it interacts directly with coilin and Sm
proteins that both concentrate in CBs (Carmo-Fonseca et al., 1992). However, this is
consistent with FRET (fluorescence resonance energy transfer) analyses that demonstrated the
self-association of SMN in CBs of living cells (Dundr et al., 2004). Indeed, we find that the
C-terminal YG-box stabilizes the localization of SMN in CBs. One explanation for the role of
the YG-box in CB localization is that self-oligomerization may enhance SMN accumulation
in CBs by promoting binding to CB components, such as snRNPs (Fischer et al., 1997; Liu et
al., 1997; Pellizzoni et al., 2001; Wang and Dreyfuss, 2001). Moreover, we show that the K-
rich region encoded by ex2B cooperates with the Tudor domain to accumulate SMN mutants
in CBs. This domain possibly stabilizes the interaction of the Tudor domain with coilin as
suggested by in vitro binding studies (Hebert et al., 2002). Other examples of proteins that
employ different protein motifs for accumulation in CBs are the transcription elongation
factor TFIIS (Smith et al., 2003), the nucleolar protein Nopp140 (Isaac et al., 1998) and the
U4/U6 snRNP assembly factor SART3/p110 (Stanèk et al., 2004). This supports the view that
nucleolar and CB components can promote on their own assembly of supramolecular nuclear
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substructures (Misteli, 2001). Moreover, proteins that transiently accumulate in dynamic
nuclear substructures may serve as molecular scaffold to concentrate nuclear factors
(reviewed in Dundr and Misteli, 2001).
Additionally, overexpression of SMN mutants lacking at least the C-terminal half of
SMN results in nucleolar accumulation of mutants. It has been reported that SMN fractionates
with nucleolar proteins in cell cultures (Whitehead et al., 2002) and concentrates in nucleoli
of some neuronal cell populations (Francis et al., 1998; Young et al., 2001a). Although, there
is no nucleolar targeting signal (Andersen et al., 2005), K-rich sequences can direct a subset
of proteins to the nucleolus (Schmidt-Zachmann and Nigg, 1993; Hebert and Matera, 2000;
Horke et al., 2004). We have identified by mutagenesis that a K-rich sequence encoded by
ex2B is required for the nucleolar accumulation of truncated SMN proteins. Furthermore, the
functional relevance of this domain has been suggested by a number of molecular interactions
(Young et al., 2000; Campbell et al., 2000; Charroux et al., 2000; Young et al., 2001b; Claus
et al., 2004). Although nucleolar localization of SMN is still debated, snRNAs and snRNP
subunits have been shown to accumulate in CBs and nucleoli (Carmo-Fonseca et al., 1992;
Leung and Lamond, 2002; Gerbi et al., 2003; Sleeman et al., 2001; Andersen et al., 2005) and
therefore, SMN might be found in nucleoli associated with snRNPs.
Defects of snRNP localization in CBs correlates with SMA disease
At the cellular level, decrease of SMN levels in SMA is reflected by a decrease in the
accumulation of SMN in NBs (Fig. 6; Coovert et al., 1997; Lefebvre et al., 1997; Frugier et
al., 2000). This implies that SMA could have consequences on the localization of snRNP in
NBs. Here, we observed that the residual SMN-positive NBs fail to accumulate snRNPs in
fibroblasts derived from patients of all three SMA types. This is consistent with the reduction
of snRNP assembly in vitro observed using extracts from fibroblast cells of SMA patients
(Wan et al., 2005). In addition, double heterozygous mice deficient in Smn and Gemin2
showed reduced levels of assembled snRNPs (Jablonska et al., 2002). Therefore, other
components involved in snRNP biogenesis might be either deficient or mislocalized in SMA
cells. Upon transient expression of FP-SMN in immortalized SMA Type I fibroblasts, we
observed that FP-SMN accumulates together with snRNPs in NBs, suggesting that
mislocalization rather than absence of factors may be associated with the SMA phenotype.
Our analyses of the SMA-linked E134K mutant revealed that this mutation is partially
defective in accumulation in coilin-positive CBs compared to FP-SMN and other SMA
mutants such as Dex7 and 472D5 that are concentrated in CBs (Table 1). The observation that
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E134K was concentrated in gems rather than in CBs supports the idea that gems and CBs are
distinct subnuclear structures and that defects in exchange between different classes of NBs
might underlie SMA pathogenesis in a subpopulation of patients. Moreover SMN-containing
gems, which are devoid of coilin, are usually not observed within nuclei of cells actively
importing new snRNPs, suggesting that overexpression of E134K might interfere with snRNP
import (Narayanan et al., 2004). Therefore, the complete colocalization of E134K and
snRNPs in CBs suggests a more complex association of SMN with snRNPs in the nucleus and
leaves open the question how this SMA mutation alters the biogenesis of snRNPs.
Transient expression of the SMN deletion mutants leads to depletion of snRNPs from
CBs similar to what is observed in SMA cells. Although coilin is required for snRNP
recruitment in CBs (Tucker et al., 2001; Hebert et al., 2001), it does not appear sufficient for
the accumulation of snRNPs in CBs of cells transfected with our mutants. This is consistent
with the idea that coilin does not regulate the dynamics of association with CBs of its
components (Platani et al., 2002; Dundr et al., 2004). Moreover, the reduction of snRNPs in
CBs of cells transfected with SMNDex7, the most frequent SMA mutation, suggests that ex7
region is important for localization of snRNPs in CBs. This is inline with the following
observations. Deletion of the SMN C-terminus encoded by ex7 diminishes the
oligomerization of SMN (Lorson et al., 1998a) and its binding capacity for the Sm proteins
(Pellizzoni et al., 1999; Wang and Dreyfuss, 2001) and for TGS1 (Mouaikel et al., 2003).
Hypermethylation of the snRNA cap structure allows efficient nuclear migration of snRNPs
(Mattaj, 1988; Fischer et al., 1991) and in turn, their passage through CBs (reviewed in Cioce
and Lamond, 2005). In light of the presence of some mutants in CBs that are devoid of
snRNPs, it is rather SMN that retains snRNPs in CBs than snRNPs that retain SMN proteins
in CBs (Carvalho et al., 1999; Sleeman et al., 2001).
The exact stoichiometry of the individual components of the SMN complex has not
been established (Carissimi et al., 2005). It is possible that the effects in the distribution of
snRNPs in CBs observed as a result of expression of the SMN mutants can be accounted for
by altered stoichiometry of the SMN complex. In the co-immunoprecipitation experiments
FP-SMN and FP-SMNDex7 associate with endogenous SMN and gemin2 in a distinct
stoichiometry. This is in agreement with the idea that truncated SMN might form partially
functional SMN complex in a dose-dependent manner. Indeed, truncated proteins rescue cell
lethality in avian cell system (Wang and Dreyfuss, 2001) and partially restore neuromuscular
functions in fruitfly larvae (Chan et al., 2003) and SMA mouse models (Le et al., 2005). Full-
length SMN might possibly gain functionality within complexes containing the mutants,
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suggesting that stabilization of SMN complexes could constitute potential therapeutics for
SMA.
The typical distribution of coilin in 2 to 8 CBs was observed upon overexpression of
FP-SMN, E143K, N86 and DC40 (Fig. 3). The number of CBs is enhanced with SMN
mutants consisting of Tudor domain with deletion of the N-terminal and/or C-terminal
regions, except with DC40. This observation suggests that DC40 does not affect the
interaction of coilin with CBs. Unexpectedly, deletion of the YG-box self-oligomerization
domain suppresses the effects of the deleted ex7 domain, indicating a functional link between
these two domains. A detailed mutagenic analysis of coilin showed that mutations of putative
phosphorylation sites resulted in similarly numerous CBs (Shpargel et al., 2003). The
serine/threonine phosphatase 4 (Carnegie et al., 2003) interacts with the SMN complex and
may regulate post-translational modifications of coilin and in turn, the formation of CBs.
In summary, we have shown that the Tudor domain plays a role in nuclear localization
of SMN and its residency in CBs by a mechanism that does require binding of additional
SMN motifs. In cells of SMA patients the remaining NBs are depleted of snRNPs, which
could induce by the expression of the most frequent SMA mutant SMNDex7. The possibility
of mimicking the SMA defect in a cell model is a step towards molecular characterization of
normal and pathological processes in vivo. Of additional interest, are the mislocalization of b-
actin mRNP in a SMA mouse model (Rossoll et al., 2003) and the lack of RNA-binding
proteins in tissues of SMA patients (Anderson et al., 2004). Thus, it has become apparent that
SMN is involved in supramolecular structuring of the nucleus and aberrant spatial
organization of ribonucleoprotein complexes might participate in SMA physiopathology.
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Legends
Figure 1. Localization of the endogenous SMN and of FP-SMN in transfected cells. In both
COS cells (A, B) and SMA type I fibroblasts (D, E), immunolocalization of the endogenous
SMN (A, D) and direct detection of FP-SMN (B, E) revealed that the protein distributes to the
cytoplasm, nucleoplasm and concentrates in CBs. The eGFP diffusely localized throughout
the cells (C, F). COS cells were double-labelled for SMN (green) and CB marker coilin (G),
gem marker gemin2 (H) and snRNP marker TMG (I, red), respectively. Inserts show SMN
colocalized with coilin, gemin2 and snRNP in CBs. Scale bars, 3 mm.
Figure 2. Systematic analysis of protein domains in subcellular distribution of SMN in
transfected cells. A) SMN is depicted with the K-rich, Tudor, P-rich, YG-box and ex7
encoded domains. SMN and deletion mutants were fused to the N-ter eGFP (FP).
Overexpressed FPs localized in the nucleus within nucleoli (No), the nucleoplasm (Np) and/or
CBs. Detection is presented as + or – for the presence or absence of protein. B) Immunoblot
analyses with anti-GFP antibodies of lysates from COS cells transiently transfected with the
indicated constructs revealed that SMN, Dex7, DC40, DN86, N194, 472D5, N86, SMNTudor,
SMNex2B recombinants and eGFP showed a major band of apparent mobility of 70, 63, 61,
57, 56, 55, 43, 39, 36 and 28 kDa, respectively. The a-SMN and a-tubulin incubations served
as loading control of and relative expression levels, respectively. The position of molecular
weight standards is indicated. C) The distribution pattern of the indicated constructs
transiently overexpressed in COS cells and analysed by fluorescence microscopy. Some FPs
accumulated in NBs (arrows) and/or in nucleoli (arrow head). D) SMN contains a conserved
interspecies K-rich sequence highlighted by open boxes (Bertrandy et al., 1999). This motif
resembles the NoLS identified in proteins such as MDM2, ARF and coilin (Hebert et al.,
2000) and corresponds to a NoLS “consensus” sequence (Horke et al., 2004). Mutagenesis of
the K-rich sequence identified a cryptic NoLS in the N-terminal portion of SMN
(SMNN86M2) and revealed a role in subnuclear localization of 472D5 (SMN472D5M2) in
CBs and nucleoli. Scale bars, 3 mm.
Figure 3. Comparison of the localization of SMN proteins with the CB marker coilin. The
constructs indicated were transiently transfected into COS cells. Overexpression of FP-SMN,
Dex7, 472D5 and DN86 colocalized with coilin in CBs (red), while N86, ex2B, Tudor, DC40
and DN189 did not form nuclear foci and were excluded from CBs. The mutants N86 and
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ex2B accumulated also in nucleoli (see Fig. S1). The microscope was focused on coilin-
positive CBs. Inserts show FPs (left), coilin (middle) and merge (right). Scale bars, 3 mm.
Figure 4. Analysis of protein domains required for nuclear localization of SMN. A) The
proportion of fluorescence in the nucleus relative to the total fluorescence contained in the
entire stack of z-sections is presented to visualize the distribution of 10 cells for each
construct. B) The 14.3.3g protein localized to the cytoplasm. The 14.3.3g fused to the SMN
ex2B region is remained in the cytoplasm, whereas fusion to the SMN Tudor domain led to
accumulation of the protein in the nucleus. Scale bars, 3 mm.
Figure 5. Accumulation of the endogenous SMN, coilin and snRNPs in CBs of COS cells
transiently transfected with SMN constructs. A) Distribution of snRNPs in cells transfected
with SMN mutants: SMN, SMNDN86, SMNDex7 and SMNTudor (green) were co-stained
using anti-TMG snRNA antibodies (red). B) Cells transfected with SMN mutants (green)
were immunolabelled for the endogenous SMN (red). C) Distribution of coilin, TMG and U2
snRNP- specific B” protein in COS cells transfected with SMNE134K mutants. D)
Distribution of the U2 snRNP-specific B” protein in cells transiently transfected with SMN
mutants. Inserts showed magnified distribution of those components in NBs of transfected
cells. E) Analyses are also presented using histograms. Scale bars, 3 mm.
Figure 6. Analyses of the interaction of the fluorescently tagged SMN mutants with the
endogenous SMN and snRNPs. A) COS cells were either transfected with the FP-SMN or FP-
SMNDex7. Immunoblotting shows no massive degradation of gem/CB components in whole-
cell extracts prepared from FACS-selected cells. B-H) Cell extracts were subject to
immunoprecipitation with anti-GFP (GFP IP) or anti-TMG snRNA antibodies (TMG IP) and
analysed by immunoblotting for the endogenous SMN. Anti-GFP incubation served as
loading control. SMN mutants co-immunoprecipated the endogenous SMN, except for the
Tudor mutant. Both FP-SMN and FP-SMNDex7 co-immunoprecipitated with anti-TMG
antibodies as confirmed with control IgG (DAKO IP). Light (lig) and heavy chains of
immunoglobulins (hig).
Figure 7. Subnuclear localization of coilin, SMN and TMG of snRNA in SMA-derived
fibroblasts. A) Immortalized control and SMA Type I patient fibroblasts were costained for
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SMN (green) and the snRNP marker TMG (red). SMN foci in control cells were colocalized
with snRNPs, as shown in the insert. In contrast, SMN foci detected in SMA cells were never
found positive for snRNP, as shown in the insert. It should be noted that coarsening of the
TMG labelling in the nucleoplasm of SMA cells was also observed in controls. B) Primary
fibroblasts derived from control and SMA Type I, II and III were immunostained for SMN
(green) and coilin (red). C) Primary fibroblasts derived from control and SMA Type I, II and
III were immunostained for SMN (green) and TMG (red). Inserts showed SMN (left), coilin
or TMG (middle) and merge (right). Scale bars, 3 mm.
Figure S1. Presence of transiently expressed N86 and SMNex2B in the nucleoli (arrow head)
of COS cells, as judged by DNA-staining with DAPI. Scale bars, 3 mm.
Figure S2. Distribution of mutant SMN Dex7 (A), 472D5 (B) and Tudor (C) observed under
transient transfection of immortalized SMA Type I fibroblast cells expressing low levels of
endogenous SMN. Immunolocalization of coilin in untransfected (D) and FP-SMN
transfected (E) SMA cells. Immunolocalization of TMG in SMA cells transfected with FP-
SMN (F). Inserts show FP-SMN (left), coilin or TMG (middle) and merge (right).  Scale bars,
3 mm.
Figure S3. Immunolocalization of the endogenous SMN and localization of the indicated
constructs transiently overexpressed in HeLa cells, and analysed by fluorescence microscopy.
Scale bar, 3 mm.
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Table 1. Analyses of CBs in transiently transfected COS cells with SMN mutants
Proportion of cells with
P80-CB
(%)
P80-positive
 FP foci (%)
endogenous
SMN foci
(%)
endogenous
SMN-positive
FP foci (%)
TMG foci
(%)
TMG-positive
FP foci (%)
U2B” foci
(%)
U2B”-
positive
FP foci
(%)
untransfected 75
(n=717)
- 71
(n=704)
- 51
(n=205)
- 39
(n=200)
-
Constructsa
SMN* 100
(n=79)
100 nd nd 46
(n=100)
46 32
(n=412)
32
SMNDN86* 95
(n=83)
100 88
(n=100)
88 9
(n=109)
9 5
(n=221)
5
SMNDex7* 100
(n=132)
100 nd - 5
(n=183)
5 6
(n=217)
6
SMNDC40 80
(n=106)
- nd - 18
(n=228)
- nd -
SMN-N194 100
(n=56)
- nd - 11
(n=107)
- nd -
SMN-Tudor 100
(n=80)
- 34
(n=300)
- 12
(n=100)
- nd -
SMN472D5* 100
(n=61)
100 16
(n=108)
16 13
(n=100)
13 16
(n=189)
16
SMN472D5M2 80
(n=100)
- nd - 16
(n=100)
- nd -
SMN-N86 100
(n=101)
- 88
(n=172)
- 53
(n=406)
- nd -
SMNE134K* 76
(n=206)
52 nd nd 58
(n=202)
54 41
(n=200)
41
a, presented in the same order as in Fig. 2A.
*, fusion proteins accumulated in CBs.
nd, not determined.











